Annexon, Inc.

ANNX Nasdaq CIK: 0001528115

Company Information

Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 1400 SIERRA POINT PARKWAY, BRISBANE, CA, 94005
Mailing Address 1400 SIERRA POINT PARKWAY, BRISBANE, CA, 94005
Phone (650) 822-5500
Fiscal Year End 1231
EIN 275414423

Financial Overview

FY2024

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment February 5, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment January 21, 2026 View on SEC
8-K Current report of material events January 14, 2026 View on SEC
8-K Current report of material events January 12, 2026 View on SEC
4 Insider stock transaction report January 2, 2026 View on SEC
4 Insider stock transaction report December 3, 2025 View on SEC
4 Insider stock transaction report December 3, 2025 View on SEC
4 Insider stock transaction report November 21, 2025 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment November 21, 2025 View on SEC
4 Insider stock transaction report November 19, 2025 View on SEC

Insider Trading

STRONG BUY 3 insiders 8 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2834)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.